236 related articles for article (PubMed ID: 23758935)
1. A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice.
Uchida Y; Tachikawa M; Obuchi W; Hoshi Y; Tomioka Y; Ohtsuki S; Terasaki T
Fluids Barriers CNS; 2013 Jun; 10(1):21. PubMed ID: 23758935
[TBL] [Abstract][Full Text] [Related]
2. Developmental changes in transporter and receptor protein expression levels at the rat blood-brain barrier based on quantitative targeted absolute proteomics.
Omori K; Tachikawa M; Hirose S; Taii A; Akanuma SI; Hosoya KI; Terasaki T
Drug Metab Pharmacokinet; 2020 Feb; 35(1):117-123. PubMed ID: 31974045
[TBL] [Abstract][Full Text] [Related]
3. Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
Zhang Z; Uchida Y; Hirano S; Ando D; Kubo Y; Auriola S; Akanuma SI; Hosoya KI; Urtti A; Terasaki T; Tachikawa M
Mol Pharm; 2017 Nov; 14(11):3729-3738. PubMed ID: 28954515
[TBL] [Abstract][Full Text] [Related]
4. Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport.
Sadiq MW; Uchida Y; Hoshi Y; Tachikawa M; Terasaki T; Hammarlund-Udenaes M
PLoS One; 2015; 10(5):e0118638. PubMed ID: 25932627
[TBL] [Abstract][Full Text] [Related]
5. Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen.
Uchida Y; Zhang Z; Tachikawa M; Terasaki T
J Neurochem; 2015 Sep; 134(6):1104-15. PubMed ID: 25951748
[TBL] [Abstract][Full Text] [Related]
6. Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks.
Uchida Y; Ohtsuki S; Kamiie J; Ohmine K; Iwase R; Terasaki T
Drug Metab Pharmacokinet; 2015 Apr; 30(2):205-8. PubMed ID: 25770030
[TBL] [Abstract][Full Text] [Related]
7. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Targeted Absolute Proteomics for 28 Transporters in Brush-Border and Basolateral Membrane Fractions of Rat Kidney.
Uchida Y; Toyohara T; Ohtsuki S; Moriyama Y; Abe T; Terasaki T
J Pharm Sci; 2016 Feb; 105(2):1011-1016. PubMed ID: 26367854
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics.
Kubo Y; Ohtsuki S; Uchida Y; Terasaki T
J Pharm Sci; 2015 Sep; 104(9):3060-8. PubMed ID: 25703048
[TBL] [Abstract][Full Text] [Related]
10. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
Zhang Z; Tachikawa M; Uchida Y; Terasaki T
Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
[TBL] [Abstract][Full Text] [Related]
11. A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundance.
Uchida Y; Takeuchi H; Goto R; Braun C; Fuchs H; Ishiguro N; Takao M; Tano M; Terasaki T
J Neurochem; 2022 Apr; 161(2):187-208. PubMed ID: 35226354
[TBL] [Abstract][Full Text] [Related]
12. Development of a method for isolating brain capillaries from a single neonatal mouse brain and comparison of proteomic profiles between neonatal and adult brain capillaries.
Hamada Y; Ogata S; Masuda T; Ito S; Ohtsuki S
Fluids Barriers CNS; 2023 Jun; 20(1):50. PubMed ID: 37353852
[TBL] [Abstract][Full Text] [Related]
13. Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs.
Takeuchi H; Suzuki M; Goto R; Tezuka K; Fuchs H; Ishiguro N; Terasaki T; Braun C; Uchida Y
Pharm Res; 2022 Jul; 39(7):1393-1413. PubMed ID: 35488144
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates.
Braun C; Sakamoto A; Fuchs H; Ishiguro N; Suzuki S; Cui Y; Klinder K; Watanabe M; Terasaki T; Sauer A
Mol Pharm; 2017 Oct; 14(10):3436-3447. PubMed ID: 28880093
[TBL] [Abstract][Full Text] [Related]
15. Application of an LC-MS/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique.
Harwood MD; Achour B; Russell MR; Carlson GL; Warhurst G; Rostami-Hodjegan A
J Pharm Biomed Anal; 2015 Jun; 110():27-33. PubMed ID: 25796981
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells.
Dehouck MP; Tachikawa M; Hoshi Y; Omori K; Maurage CA; Strecker G; Dehouck L; Boucau MC; Uchida Y; Gosselet F; Terasaki T; Karamanos Y
Cells; 2022 Dec; 11(24):. PubMed ID: 36552728
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative Targeted Absolute Proteomics (QTAP)-based Pharmacoproteomics: The Importance of International Collaboration].
Terasaki T
Yakugaku Zasshi; 2017; 137(6):685-689. PubMed ID: 28566574
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line.
Pelkonen L; Sato K; Reinisalo M; Kidron H; Tachikawa M; Watanabe M; Uchida Y; Urtti A; Terasaki T
Mol Pharm; 2017 Mar; 14(3):605-613. PubMed ID: 28112518
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Proteomics-Based Blood-Brain Barrier Study.
Uchida Y
Biol Pharm Bull; 2021; 44(4):465-473. PubMed ID: 33790097
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS-based quantification of efflux transporter proteins at the BBB.
Gomez-Zepeda D; Taghi M; Smirnova M; Sergent P; Liu WQ; Chhuon C; Vidal M; Picard M; Thioulouse E; Broutin I; Guerrera IC; Scherrmann JM; Parmentier Y; Decleves X; Menet MC
J Pharm Biomed Anal; 2019 Feb; 164():496-508. PubMed ID: 30453156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
